drugset / Trial / NCT00388219
Single Dose Trial Comparing the Plasma Levels of Two Different Analgesic Transdermal Patch Formulations
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to determine whether Transtec (R) PRO 70 µg/h and a new buprenorphine patch formulation lead to same plasma levels of buprenorphine after single dose application
Timeline
- Start
- 2006-10
- Primary completion
- —
- Completion
- 2006-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Buprenorphine | Other / unclassified | 40 mg | Other |
Indications
No indication recorded.